Skip to content

Clinical trials

Completed Candidiasis, Invasive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Candidiasis, Invasive Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20061
20076
20084
20091
20102
20123
20132
20143
20154
20162
20173
20183
20191
20202
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
Astellas Pharma Inc4
Scynexis, Inc.3
University Medical Center Groningen3
Central Hospital, Nancy, France2
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
Duke University2
Medical University of Graz2
Merck Sharp & Dohme LLC2
University Hospital, Lille2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Candidiasis, Invasive46
Candidemia21
Candidiasis13
Critical Illness5
Mycoses5
Invasive Fungal Infections4
Aspergillosis3
Fungemia3
Pathologic Processes2
Sepsis2

Trials

Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.